Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry. [electronic resource]
Producer: 20170531Description: 948-956 p. digitalISSN:- 1097-0142
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor
- Breast Neoplasms -- diagnosis
- Clinical Decision-Making
- Female
- Gene Expression Profiling -- methods
- Genetic Testing
- Humans
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- genetics
- Neoplasm Staging
- Prognosis
- Registries
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.